Attorneys

David W. Osborne is an equity partner and senior attorney in the chemical practice group of Thorpe North & Western, LLP. His legal practice encompasses all areas of intellectual property law with a focus on the procurement and exploitation of intellectual property assets, including U.S. and foreign patents, trademarks, and copyrights. David’s practice also includes client counseling in patent portfolio strategy and development, technology licensing, and product marketing clearance.

David’s technical expertise lies primarily in the areas of biology and chemistry with particular emphasis in the health and life science fields. He has procured U.S. and foreign patents for clients in the pharmaceutical and nutritional supplement areas, as well as in other chemistry and biology related disciplines, including compound and molecule identification and analysis, ink and print substrate compositions, medical devices, diamond and superabrasive tools, and semi-conductor fabrication. One area of particular focus continues to be drug delivery formulations for oral, transmucosal, ocular and transdermal delivery.

David is also experienced in negotiating and preparing license and technology transfer agreements, patent litigation planning and support, and the preparation of legal opinions, including opinions in support of ANDA filings under the Hatch-Waxman amendments to the Federal Food, Drug & Cosmetic Act.

David holds a B.S. in Biology with a minor in Chemistry from Brigham Young University, and a Juris Doctor from the Franklin Pierce Law Center. During his undergraduate studies, David worked as a researcher in the field of microbiology on various projects funded by the National Institute of Health and gained technical experience with various aspects of nucleic acid and protein manipulation and analysis. Following graduation, and prior to attending law school, David worked for several years as an analytical chemist for companies in the en